Lupin enters prescription dermatology segment in Brazil

Valued at USD 28 billion, Brazil is the world's sixth largest pharmaceutical market, driven by growing public health expenditure and increasing household income.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2Pu4xto
via IFTTT

0 comments:

Post a Comment